The Med-Tech company PolarCool AB (publ.) continues to expand its presence in European ice hockey, signing its first agreement in the Czech Republic’s top league, Extraliga. BK Mladá Boleslav becomes the first club in the league to integrate the PolarCap® System into their concussions management protocols.

Entering the Czech Extraliga, one of Europe’s highest-ranked hockey leagues, marks another significant step forward in the company’s expansion. PolarCool now has a strong presence in several of Europe’s largest hockey leagues, including Sweden, Finland, Denmark, Germany, Austria, the United Kingdom, and Switzerland.

As part of its commitment to player safety, BK Mladá Boleslav will be the first club in the league to use the PolarCap® System to treat players suffering from concussions.

PolarCool’s CEO Erik Andersson comments;

-I am very pleased that we have secured our first PolarCap® agreement in the Czech Republic, a country with a strong hockey tradition and a top-tier league. BK Mladá Boleslav will serve as an important ambassador for our technology in the region. We look forward to collaborating with the club and anticipate that more teams in the Extraliga will follow.

The agreement with BK Mladá Boleslav represents a strategic breakthrough in the Czech Republic. While individual agreements have limited financial impact, they are an essential part of PolarCool’s long-term growth strategy and ambition to strengthen its position in the European market.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 – 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.